If you enjoy this content, please share it with a colleague
Philips
RELATED CONTENT
“The only constant in healthcare these days is change,” said Samantha E. Sizemore, chief operating officer/director of ...
Positron emission tomography (PET) is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical turf is sports medicine.
The following is a summary of a study published in the European Journal of Radiology, 105 (2018) 216–220, by Victor ...
As the world’s most utilized medical imaging modality, ultrasound is likely to be featured heavily at the 2018 Radiologi ...
According to an industry market report released by Mordor Intelligence in May 2018, the computed tomography (CT) market ...
Philips announced what it calls its ultimate ultrasound solution for breast assessment, available with the Philips Epiq and Affiniti ultrasound systems, and the combination of the eL18-4 transducer and anatomical intelligence. This all-in-one solution brings together high-quality imaging with complementary clinical tools tailored for breast screenings. With the new breast solution, clinicians can efficiently assess, monitor and treat breast diseases, increasing diagnostic confidence and helping to improve patient care.
Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology at Henry Ford Health System, describes ...
When Cullman Regional Medical Center in Alabama decided to switch from 2-D to 3-D mammography, they knew they needed to ...
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing its latest solutions in interventional cardiology. These solutions combine imaging systems, planning and navigation software, and specialized diagnostic and therapeutic devices, helping clinicians conduct procedures that are fast, efficient and personalized.
September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T magnetic resonance imaging (MRI) scanne ...